img

Global Controlled-Release Drug Delivery Systems Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Controlled-Release Drug Delivery Systems Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Controlled-Release Drug Delivery Systems market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Controlled-Release Drug Delivery Systems market research.
Key manufacturers engaged in the Controlled-Release Drug Delivery Systems industry include Depomed, Coating Place, Corium International, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel and Merck and Co, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Controlled-Release Drug Delivery Systems were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Controlled-Release Drug Delivery Systems market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Controlled-Release Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Depomed
Coating Place
Corium International
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck and Co
Aradigm
Segment by Type
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others

Segment by Application


Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Controlled-Release Drug Delivery Systems report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Controlled-Release Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Controlled-Release Drug Delivery Systems
1.2 Controlled-Release Drug Delivery Systems Segment by Type
1.2.1 Global Controlled-Release Drug Delivery Systems Market Value Comparison by Type (2024-2034)
1.2.2 Wurster Technique
1.2.3 Coacervation
1.2.4 Micro Encapsulation
1.2.5 Implants
1.2.6 Transdermal
1.2.7 Targeted Delivery
1.2.8 Others
1.3 Controlled-Release Drug Delivery Systems Segment by Application
1.3.1 Global Controlled-Release Drug Delivery Systems Market Value by Application: (2024-2034)
1.3.2 Metered Dose Inhalers
1.3.3 Injectables
1.3.4 Transdermal and Ocular Patches
1.3.5 Infusion Pumps
1.3.6 Oral Controlled-Drug Delivery Systems
1.3.7 Drug Eluting Stents
1.3.8 Others
1.4 Global Controlled-Release Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Controlled-Release Drug Delivery Systems Revenue 2018-2034
1.4.2 Global Controlled-Release Drug Delivery Systems Sales 2018-2034
1.4.3 Global Controlled-Release Drug Delivery Systems Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Controlled-Release Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Controlled-Release Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Controlled-Release Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Controlled-Release Drug Delivery Systems Average Price by Manufacturers (2018-2023)
2.4 Global Controlled-Release Drug Delivery Systems Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Controlled-Release Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Controlled-Release Drug Delivery Systems, Product Type & Application
2.7 Controlled-Release Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Controlled-Release Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Controlled-Release Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Controlled-Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Controlled-Release Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Controlled-Release Drug Delivery Systems Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Controlled-Release Drug Delivery Systems Global Controlled-Release Drug Delivery Systems Sales by Region: 2018-2034
3.2.1 Global Controlled-Release Drug Delivery Systems Sales by Region: 2018-2023
3.2.2 Global Controlled-Release Drug Delivery Systems Sales by Region: 2024-2034
3.3 Global Controlled-Release Drug Delivery Systems Global Controlled-Release Drug Delivery Systems Revenue by Region: 2018-2034
3.3.1 Global Controlled-Release Drug Delivery Systems Revenue by Region: 2018-2023
3.3.2 Global Controlled-Release Drug Delivery Systems Revenue by Region: 2024-2034
3.4 North America Controlled-Release Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Controlled-Release Drug Delivery Systems Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Controlled-Release Drug Delivery Systems Sales by Country (2018-2034)
3.4.3 North America Controlled-Release Drug Delivery Systems Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Controlled-Release Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Controlled-Release Drug Delivery Systems Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Controlled-Release Drug Delivery Systems Sales by Country (2018-2034)
3.5.3 Europe Controlled-Release Drug Delivery Systems Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Controlled-Release Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Controlled-Release Drug Delivery Systems Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Controlled-Release Drug Delivery Systems Sales by Country (2018-2034)
3.6.3 Asia Pacific Controlled-Release Drug Delivery Systems Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Controlled-Release Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Controlled-Release Drug Delivery Systems Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Controlled-Release Drug Delivery Systems Sales by Country (2018-2034)
3.7.3 Latin America Controlled-Release Drug Delivery Systems Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Controlled-Release Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Controlled-Release Drug Delivery Systems Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Controlled-Release Drug Delivery Systems Sales by Country (2018-2034)
3.8.3 Middle East and Africa Controlled-Release Drug Delivery Systems Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Controlled-Release Drug Delivery Systems Sales by Type (2018-2034)
4.1.1 Global Controlled-Release Drug Delivery Systems Sales by Type (2018-2023)
4.1.2 Global Controlled-Release Drug Delivery Systems Sales by Type (2024-2034)
4.1.3 Global Controlled-Release Drug Delivery Systems Sales Market Share by Type (2018-2034)
4.2 Global Controlled-Release Drug Delivery Systems Revenue by Type (2018-2034)
4.2.1 Global Controlled-Release Drug Delivery Systems Revenue by Type (2018-2023)
4.2.2 Global Controlled-Release Drug Delivery Systems Revenue by Type (2024-2034)
4.2.3 Global Controlled-Release Drug Delivery Systems Revenue Market Share by Type (2018-2034)
4.3 Global Controlled-Release Drug Delivery Systems Price by Type (2018-2034)
5 Segment by Application
5.1 Global Controlled-Release Drug Delivery Systems Sales by Application (2018-2034)
5.1.1 Global Controlled-Release Drug Delivery Systems Sales by Application (2018-2023)
5.1.2 Global Controlled-Release Drug Delivery Systems Sales by Application (2024-2034)
5.1.3 Global Controlled-Release Drug Delivery Systems Sales Market Share by Application (2018-2034)
5.2 Global Controlled-Release Drug Delivery Systems Revenue by Application (2018-2034)
5.2.1 Global Controlled-Release Drug Delivery Systems Revenue by Application (2018-2023)
5.2.2 Global Controlled-Release Drug Delivery Systems Revenue by Application (2024-2034)
5.2.3 Global Controlled-Release Drug Delivery Systems Revenue Market Share by Application (2018-2034)
5.3 Global Controlled-Release Drug Delivery Systems Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Depomed
6.1.1 Depomed Corporation Information
6.1.2 Depomed Description and Business Overview
6.1.3 Depomed Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Depomed Controlled-Release Drug Delivery Systems Product Portfolio
6.1.5 Depomed Recent Developments/Updates
6.2 Coating Place
6.2.1 Coating Place Corporation Information
6.2.2 Coating Place Description and Business Overview
6.2.3 Coating Place Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Coating Place Controlled-Release Drug Delivery Systems Product Portfolio
6.2.5 Coating Place Recent Developments/Updates
6.3 Corium International
6.3.1 Corium International Corporation Information
6.3.2 Corium International Description and Business Overview
6.3.3 Corium International Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Corium International Controlled-Release Drug Delivery Systems Product Portfolio
6.3.5 Corium International Recent Developments/Updates
6.4 Johnson and Johnson
6.4.1 Johnson and Johnson Corporation Information
6.4.2 Johnson and Johnson Description and Business Overview
6.4.3 Johnson and Johnson Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson and Johnson Controlled-Release Drug Delivery Systems Product Portfolio
6.4.5 Johnson and Johnson Recent Developments/Updates
6.5 Alkermes
6.5.1 Alkermes Corporation Information
6.5.2 Alkermes Description and Business Overview
6.5.3 Alkermes Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Alkermes Controlled-Release Drug Delivery Systems Product Portfolio
6.5.5 Alkermes Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Controlled-Release Drug Delivery Systems Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Orbis Biosciences
6.6.1 Orbis Biosciences Corporation Information
6.6.2 Orbis Biosciences Description and Business Overview
6.6.3 Orbis Biosciences Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Orbis Biosciences Controlled-Release Drug Delivery Systems Product Portfolio
6.7.5 Orbis Biosciences Recent Developments/Updates
6.8 Capsugel
6.8.1 Capsugel Corporation Information
6.8.2 Capsugel Description and Business Overview
6.8.3 Capsugel Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Capsugel Controlled-Release Drug Delivery Systems Product Portfolio
6.8.5 Capsugel Recent Developments/Updates
6.9 Merck and Co
6.9.1 Merck and Co Corporation Information
6.9.2 Merck and Co Description and Business Overview
6.9.3 Merck and Co Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck and Co Controlled-Release Drug Delivery Systems Product Portfolio
6.9.5 Merck and Co Recent Developments/Updates
6.10 Aradigm
6.10.1 Aradigm Corporation Information
6.10.2 Aradigm Description and Business Overview
6.10.3 Aradigm Controlled-Release Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Aradigm Controlled-Release Drug Delivery Systems Product Portfolio
6.10.5 Aradigm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Controlled-Release Drug Delivery Systems Industry Chain Analysis
7.2 Controlled-Release Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Controlled-Release Drug Delivery Systems Production Mode & Process
7.4 Controlled-Release Drug Delivery Systems Sales and Marketing
7.4.1 Controlled-Release Drug Delivery Systems Sales Channels
7.4.2 Controlled-Release Drug Delivery Systems Distributors
7.5 Controlled-Release Drug Delivery Systems Customers
8 Controlled-Release Drug Delivery Systems Market Dynamics
8.1 Controlled-Release Drug Delivery Systems Industry Trends
8.2 Controlled-Release Drug Delivery Systems Market Drivers
8.3 Controlled-Release Drug Delivery Systems Market Challenges
8.4 Controlled-Release Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Controlled-Release Drug Delivery Systems Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Controlled-Release Drug Delivery Systems Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Controlled-Release Drug Delivery Systems Market Competitive Situation by Manufacturers in 2024
Table 4. Global Controlled-Release Drug Delivery Systems Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Controlled-Release Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Controlled-Release Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Controlled-Release Drug Delivery Systems Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Controlled-Release Drug Delivery Systems Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Controlled-Release Drug Delivery Systems, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Controlled-Release Drug Delivery Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Controlled-Release Drug Delivery Systems, Product Type & Application
Table 12. Global Key Manufacturers of Controlled-Release Drug Delivery Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Controlled-Release Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Controlled-Release Drug Delivery Systems as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Controlled-Release Drug Delivery Systems Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Controlled-Release Drug Delivery Systems Sales by Region (2018-2023) & (K Units)
Table 18. Global Controlled-Release Drug Delivery Systems Sales Market Share by Region (2018-2023)
Table 19. Global Controlled-Release Drug Delivery Systems Sales by Region (2024-2034) & (K Units)
Table 20. Global Controlled-Release Drug Delivery Systems Sales Market Share by Region (2024-2034)
Table 21. Global Controlled-Release Drug Delivery Systems Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Region (2018-2023)
Table 23. Global Controlled-Release Drug Delivery Systems Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Region (2024-2034)
Table 25. North America Controlled-Release Drug Delivery Systems Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Controlled-Release Drug Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 27. North America Controlled-Release Drug Delivery Systems Sales by Country (2024-2034) & (K Units)
Table 28. North America Controlled-Release Drug Delivery Systems Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Controlled-Release Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Controlled-Release Drug Delivery Systems Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Controlled-Release Drug Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 32. Europe Controlled-Release Drug Delivery Systems Sales by Country (2024-2034) & (K Units)
Table 33. Europe Controlled-Release Drug Delivery Systems Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Controlled-Release Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Controlled-Release Drug Delivery Systems Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Controlled-Release Drug Delivery Systems Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Controlled-Release Drug Delivery Systems Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Controlled-Release Drug Delivery Systems Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Controlled-Release Drug Delivery Systems Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Controlled-Release Drug Delivery Systems Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Controlled-Release Drug Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Controlled-Release Drug Delivery Systems Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Controlled-Release Drug Delivery Systems Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Controlled-Release Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Controlled-Release Drug Delivery Systems Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Controlled-Release Drug Delivery Systems Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Controlled-Release Drug Delivery Systems Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Controlled-Release Drug Delivery Systems Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Controlled-Release Drug Delivery Systems Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Controlled-Release Drug Delivery Systems Sales (K Units) by Type (2018-2023)
Table 51. Global Controlled-Release Drug Delivery Systems Sales (K Units) by Type (2024-2034)
Table 52. Global Controlled-Release Drug Delivery Systems Sales Market Share by Type (2018-2023)
Table 53. Global Controlled-Release Drug Delivery Systems Sales Market Share by Type (2024-2034)
Table 54. Global Controlled-Release Drug Delivery Systems Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Controlled-Release Drug Delivery Systems Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Type (2018-2023)
Table 57. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Type (2024-2034)
Table 58. Global Controlled-Release Drug Delivery Systems Price (USD/Unit) by Type (2018-2023)
Table 59. Global Controlled-Release Drug Delivery Systems Price (USD/Unit) by Type (2024-2034)
Table 60. Global Controlled-Release Drug Delivery Systems Sales (K Units) by Application (2018-2023)
Table 61. Global Controlled-Release Drug Delivery Systems Sales (K Units) by Application (2024-2034)
Table 62. Global Controlled-Release Drug Delivery Systems Sales Market Share by Application (2018-2023)
Table 63. Global Controlled-Release Drug Delivery Systems Sales Market Share by Application (2024-2034)
Table 64. Global Controlled-Release Drug Delivery Systems Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Controlled-Release Drug Delivery Systems Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Application (2018-2023)
Table 67. Global Controlled-Release Drug Delivery Systems Revenue Market Share by Application (2024-2034)
Table 68. Global Controlled-Release Drug Delivery Systems Price (USD/Unit) by Application (2018-2023)
Table 69. Global Controlled-Release Drug Delivery Systems Price (USD/Unit) by Application (2024-2034)
Table 70. Depomed Corporation Information
Table 71. Depomed Description and Business Overview
Table 72. Depomed Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Depomed Controlled-Release Drug Delivery Systems Product
Table 74. Depomed Recent Developments/Updates
Table 75. Coating Place Corporation Information
Table 76. Coating Place Description and Business Overview
Table 77. Coating Place Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Coating Place Controlled-Release Drug Delivery Systems Product
Table 79. Coating Place Recent Developments/Updates
Table 80. Corium International Corporation Information
Table 81. Corium International Description and Business Overview
Table 82. Corium International Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Corium International Controlled-Release Drug Delivery Systems Product
Table 84. Corium International Recent Developments/Updates
Table 85. Johnson and Johnson Corporation Information
Table 86. Johnson and Johnson Description and Business Overview
Table 87. Johnson and Johnson Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Johnson and Johnson Controlled-Release Drug Delivery Systems Product
Table 89. Johnson and Johnson Recent Developments/Updates
Table 90. Alkermes Corporation Information
Table 91. Alkermes Description and Business Overview
Table 92. Alkermes Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Alkermes Controlled-Release Drug Delivery Systems Product
Table 94. Alkermes Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Pfizer Controlled-Release Drug Delivery Systems Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Orbis Biosciences Corporation Information
Table 101. Orbis Biosciences Description and Business Overview
Table 102. Orbis Biosciences Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Orbis Biosciences Controlled-Release Drug Delivery Systems Product
Table 104. Orbis Biosciences Recent Developments/Updates
Table 105. Capsugel Corporation Information
Table 106. Capsugel Description and Business Overview
Table 107. Capsugel Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Capsugel Controlled-Release Drug Delivery Systems Product
Table 109. Capsugel Recent Developments/Updates
Table 110. Merck and Co Corporation Information
Table 111. Merck and Co Description and Business Overview
Table 112. Merck and Co Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Merck and Co Controlled-Release Drug Delivery Systems Product
Table 114. Merck and Co Recent Developments/Updates
Table 115. Aradigm Corporation Information
Table 116. Aradigm Description and Business Overview
Table 117. Aradigm Controlled-Release Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Aradigm Controlled-Release Drug Delivery Systems Product
Table 119. Aradigm Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Controlled-Release Drug Delivery Systems Distributors List
Table 123. Controlled-Release Drug Delivery Systems Customers List
Table 124. Controlled-Release Drug Delivery Systems Market Trends
Table 125. Controlled-Release Drug Delivery Systems Market Drivers
Table 126. Controlled-Release Drug Delivery Systems Market Challenges
Table 127. Controlled-Release Drug Delivery Systems Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Controlled-Release Drug Delivery Systems
Figure 2. Global Controlled-Release Drug Delivery Systems Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Controlled-Release Drug Delivery Systems Market Share by Type in 2024 & 2034
Figure 4. Wurster Technique Product Picture
Figure 5. Coacervation Product Picture
Figure 6. Micro Encapsulation Product Picture
Figure 7. Implants Product Picture
Figure 8. Transdermal Product Picture
Figure 9. Targeted Delivery Product Picture
Figure 10. Others Product Picture
Figure 11. Global Controlled-Release Drug Delivery Systems Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 12. Global Controlled-Release Drug Delivery Systems Market Share by Application in 2024 & 2034
Figure 13. Metered Dose Inhalers
Figure 14. Injectables
Figure 15. Transdermal and Ocular Patches
Figure 16. Infusion Pumps
Figure 17. Oral Controlled-Drug Delivery Systems
Figure 18. Drug Eluting Stents
Figure 19. Others
Figure 20. Global Controlled-Release Drug Delivery Systems Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 21. Global Controlled-Release Drug Delivery Systems Market Size (2018-2034) & (US$ Million)
Figure 22. Global Controlled-Release Drug Delivery Systems Sales (2018-2034) & (K Units)
Figure 23. Global Controlled-Release Drug Delivery Systems Average Price (USD/Unit) & (2018-2034)
Figure 24. Controlled-Release Drug Delivery Systems Report Years Considered
Figure 25. Controlled-Release Drug Delivery Systems Sales Share by Manufacturers in 2024
Figure 26. Global Controlled-Release Drug Delivery Systems Revenue Share by Manufacturers in 2024
Figure 27. The Global 5 and 10 Largest Controlled-Release Drug Delivery Systems Players: Market Share by Revenue in 2024
Figure 28. Controlled-Release Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 29. Global Controlled-Release Drug Delivery Systems Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 30. North America Controlled-Release Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 31. North America Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 32. U.S. Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Canada Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Europe Controlled-Release Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 35. Europe Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 36. Germany Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. France Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. U.K. Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Italy Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Russia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Asia Pacific Controlled-Release Drug Delivery Systems Sales Market Share by Region (2018-2034)
Figure 42. Asia Pacific Controlled-Release Drug Delivery Systems Revenue Market Share by Region (2018-2034)
Figure 43. China Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Japan Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. South Korea Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. India Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Australia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Taiwan Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Indonesia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Thailand Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Malaysia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Philippines Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Latin America Controlled-Release Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 54. Latin America Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 55. Mexico Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Brazil Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Argentina Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Middle East & Africa Controlled-Release Drug Delivery Systems Sales Market Share by Country (2018-2034)
Figure 59. Middle East & Africa Controlled-Release Drug Delivery Systems Revenue Market Share by Country (2018-2034)
Figure 60. Turkey Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 61. Saudi Arabia Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 62. U.A.E Controlled-Release Drug Delivery Systems Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 63. Global Sales Market Share of Controlled-Release Drug Delivery Systems by Type (2018-2034)
Figure 64. Global Revenue Market Share of Controlled-Release Drug Delivery Systems by Type (2018-2034)
Figure 65. Global Controlled-Release Drug Delivery Systems Price (USD/Unit) by Type (2018-2034)
Figure 66. Global Sales Market Share of Controlled-Release Drug Delivery Systems by Application (2018-2034)
Figure 67. Global Revenue Market Share of Controlled-Release Drug Delivery Systems by Application (2018-2034)
Figure 68. Global Controlled-Release Drug Delivery Systems Price (USD/Unit) by Application (2018-2034)
Figure 69. Controlled-Release Drug Delivery Systems Value Chain
Figure 70. Controlled-Release Drug Delivery Systems Production Process
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Distributors Profiles
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed